Literature DB >> 28753820

Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy.

Marco Moschini1, Alessandro Morlacco2, Alberto Briganti3, Brian Hu4, Renzo Colombo3, Francesco Montorsi3, Igor Frank2, Siamak Daneshmand4, R Jeffrey Karnes5.   

Abstract

BACKGROUND: Data regarding clinical node metastases (cN+) in patients undergoing radical cystectomy (RC) are scarce.
OBJECTIVE: To evaluate the performance of conventional imaging in detecting cN+ and analyze the impact of cN+ on survival among patients treated with RC without neoadjuvant chemotherapy (NAC). DESIGN, SETTING, AND PARTICIPANTS: Data from three independent centers of consecutive patients with bladder cancer treated with RC without NAC were analyzed. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: cN+ was defined as pelvic nodes >8mm or abdominal nodes >10mm in maximum short-axis diameter as detected via preoperative computed tomography or magnetic resonance imaging. Performance characteristics were evaluated considering pN+ disease as the reference standard. Multivariable Cox regression analyses were performed for prediction of survival. RESULTS AND LIMITATIONS: Overall, 196 patients (7.1%) had cN+ disease before RC and pN+ status was confirmed for 122 of them (62.2%). cN+ status in the overall population had sensitivity of 18% and specificity of 96% with a calculated area under the curve of 57%. The median follow-up was 108 mo. On multivariable analyses, cN+pN+ (hazard ratio [HR] 1.84, 95% confidence interval [CI] 1.26-2.68) and cN-pN+ (HR 2.36, 95% CI 1.90-2.92) were predictors of CSM (both p<0.001). Conversely, cN+pN- status was not associated with worse survival outcomes (p > 0.2).
CONCLUSIONS: Our study confirms the poor accuracy of conventional preoperative imaging in assessing nodal disease status. cN status had no independent impact on survival when all confounders were evaluated, and potentially curative treatments should not be withheld on the basis of clinical nodal status alone. PATIENT
SUMMARY: The accuracy of conventional imaging techniques for detection of pathologic lymph node-positive disease before radical cystectomy for bladder cancer is suboptimal. The presence of clinical lymph node positivity on preoperative imaging is not an independent predictor of oncologic outcomes, and if the node invasion is not confirmed at radical cystectomy, these patients may have good long-term outcomes.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Clinical lymph node; Lymph node invasion; Lymph node metastases; Radical cystectomy

Mesh:

Year:  2016        PMID: 28753820     DOI: 10.1016/j.euf.2016.11.005

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  8 in total

1.  Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.

Authors:  Marco Moschini; Agostino Mattei; Julian Cornelius; Shahrokh F Shariat; Paolo Dell'Oglio; Emanuele Zaffuto; Andrea Salonia; Francesco Montorsi; Alberto Briganti; Renzo Colombo; Andrea Gallina
Journal:  World J Urol       Date:  2018-01-24       Impact factor: 4.226

2.  Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases.

Authors:  Marco Moschini; Stefania Zamboni; Agostino Mattei; Alberto Martini; Emanuele Zaffuto; Alberto Briganti; Andrea Gallina; Francesco Montorsi
Journal:  Transl Androl Urol       Date:  2018-08

3.  Preoperative Prediction of Node Metastases in Bladder Cancer Patients Using Genomic and Clinicopathologic Data.

Authors:  Marco Moschini; Francesco Montorsi
Journal:  EBioMedicine       Date:  2018-04-07       Impact factor: 8.143

Review 4.  Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Authors:  Gautier Marcq; Edouard Jarry; Idir Ouzaid; Jean-François Hermieu; François Henon; Jean-Christophe Fantoni; Evanguelos Xylinas
Journal:  Ther Adv Urol       Date:  2019-01-28

Review 5.  The evolving role of lymphadenectomy for bladder cancer: why, when, and how.

Authors:  Vignesh T Packiam; Matvey Tsivian; Stephen A Boorjian
Journal:  Transl Androl Urol       Date:  2020-12

Review 6.  The Role of Lymph Node Dissection in the Treatment of Bladder Cancer.

Authors:  Francesco Cattaneo; Giovanni Motterle; Filiberto Zattoni; Alessandro Morlacco; Fabrizio Dal Moro
Journal:  Front Surg       Date:  2018-10-05

Review 7.  The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.

Authors:  Roberto Carando; Luca Afferi; Giancarlo Marra; Wojciech Krajewski; Vincenzo Pagliarulo; Mohammad Abufaraj; Evanguelos Xylinas; Xavier Cathelineau; Rafael Sanchez-Salas; Marco Moschini
Journal:  Arab J Urol       Date:  2020-03-01

8.  Chemotherapy Versus Chemoradiation for Node-Positive Bladder Cancer: Practice Patterns and Outcomes from the National Cancer Data Base.

Authors:  Waqar Haque; Vivek Verma; E Brian Butler; Bin S Teh
Journal:  Bladder Cancer       Date:  2017-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.